Background: Due to laryngeal neoplasia, as well as infectious and autoimmune diseases, the subglottic region is of great clinical relevance. However, descriptions of the subglottic structures are inconsistent. The aim of our study was to present a precise analysis of the subglottic region and derive functional and clinical conclusions. Methods: Histological, histochemical and immunohistochemical investigations as well as scanning electron microscopy were performed and combined with injection techniques applied to the subglottic region of the larynges of 33 body donors. Results: The three-dimensional extensions of the subglottic region were newly defined: the inferior arcuate line of the vocal cord was defined as the cranial border. The lower margin of the cricoid is the caudal border. Craniolaterally, the elastic cone and, further caudally, the cricoid form the border. Therefore, the definition presented comprises heretofore unnamed ventral and dorsal parts of the lower larynx. The subglottic region can be described as cylindrical, becoming smaller in the cranial direction, following the elastic cone. The ventral boundary is formed by the median part of the cricothyroid ligament (ligamentum conicum), the dorsal part by the cricoid cartilage. The walls of the subglottis are divided into three or four layers composed of collagenous and elastic fibres in which seromucous glands are embedded. Subglottic blood vessels including a tight subepithelial capillary plexus were delineated. Conclusion: The new definition of the subglottic extensions presented is helpful and essential for precise laryngeal tumour classification. The results indicate that the boundaries are unlikely to counteract tumour progression in the subglottis. Furthermore, the findings suggest that these structures contribute to temperature regulation of breath, protection against inflammation as well as breath frequency and depth-dependent mucus secretion.

1.
Becker, W., H.H. Naumann, C.R. Pfaltz (1989) Hals-Nasen-Ohrenheilkunde. Stuttgart, Thieme.
2.
Friedrich, E.P. (1896) Die elastischen Fasern im Kehlkopfe. Arch Laryngol Rhinol 4: 186–209.
3.
Gray, H. (2005) Gray’s Anatomy. The Anatomical Basis of Clinical Practice, ed 39. Edinburgh, Churchill Livingstone, Elsevier.
4.
Hafferl, A. (1957) Lehrbuch der topographischen Anatomie. Berlin, Springer.
5.
Kirchner, J.A., D. Carter (1987) Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol 103: 503–513.
6.
Kleinsasser, O. (1987) Tumoren des Larynx und des Hypopharynx. New York, Thieme.
7.
Lorenz, R.R. (2003) Adult laryngotracheal stenosis: etiology and surgical management. Curr Opin Otolaryngol Head Neck Surg 11: 467–472.
8.
Morgagni, J.B. (1762) Adversaria anatomica omnia novis pluribus aereis tabulis et universali accuratissimo indice ornata. Opus nunc vere absolutum etc. Quibus universa humani corporis anatome et subinde etiam quae ab hac pendent res medica et chirurgica admodum illustrantur. Venetiis, Typographica Remondiniana.
9.
Ohtani, O., T. Ushiki, T. Taguchi, A. Kikuta (1988) Collagen fibrillar networks as skeletal frameworks: a demonstration by cell-maceration/scanning electron microscope method. Arch Histol Cytol 51: 249–261.
10.
Pastor, L.M., A. Ferran, A. Calvo, C. Sprekelsen, R. Horn, J.A. Marin (1994) Morphological and histochemical study of human submucosal laryngeal glands. Anat Rec 239: 453–467.
11.
Paulsen, J.I., H. Rudert (2001) Erscheinungsbild primärer Vaskulitiden im HNO-Bereich. Z Rheumatol 60: 219–225.
12.
Pernkopf, E. (1952) Topographische Anatomie des Menschen. Wien, Urban & Schwarzenberg.
13.
Probst, R., G. Grevers, H. Iro (2000) Hals-Nasen-Ohren-Heilkunde. Stuttgart, Thieme.
14.
Reidenbach, M.M. (1995) Normal topography of the conus elasticus. Anatomical bases for the spread of laryngeal cancer. Surg Radiol Anat 17: 107–111, 114–115.
15.
Reidenbach, M.M. (1998) Subglottic region: normal topography and possible clinical implications. Clin Anat 11: 9–21.
16.
Reinke, F. (1897) Über die funktionelle Struktur der menschlichen Stimmlippe mit besonderer Berücksichtigung des elastischen Gewebes. Anat Hefte 9: 105–116.
17.
Romeis, B. (1989) Mikroskopische Technik. München, Urban & Schwarzenberg.
18.
Silver CE (1981) Surgery for Cancer of the Larynx and Related Structures. New York, Churchill Livingstone.
19.
Steven, P., F.P. Paulsen, B. Tillmann (2000) Orcein-picroindigocarmine – a new multiple stain. Arch Histol Cytol 63: 397–400.
20.
Strome, S.E., T.C. Robey, K.O. Devaney, C.J. Krause, N.D. Hogikyan (1999) Subglottic carcinoma: review of a series and characterization of its patterns of spread. Ear Nose Throat J 78: 622–624, 626, 628.
21.
Tillmann, B., F. Wustrow (1982) Kehlkopf; in Berendes, J., R. Link, F. Zöllner (eds): Hals-Nasen-Ohrenheilkunde, Handbuch in sechs Bänden. Stuttgart, Thieme, pp 1.1–1.101.
22.
Tucker, G.F., H.R. Smith (1962) A histological demonstration of the development of laryngeal connective tissue compartments. Trans Am Acad Ophthalmol Otolaryngol 66: 308–318.
23.
von Luschka, H. (1871) Der Kehlkopf des Menschen. Tübingen, Viehweg, pp 43–86.
24.
Werner, J.A. (1995) Morphologie und Histochemie von Lymphgefäβen der oberen Luft- und Speisewege: eine klinisch orientierte Untersuchung. Laryngorhinootologie 74: 568–576.
25.
Zenker, W. (1958) Über die Bindegewebsstrukturen des Kehlkopfes und seines Aufhängesystems und deren funktionelle Bedeutung für den Kehlkopfraum. Monatsschr Ohrenheilkd 92: 269–383.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.